Record Information |
---|
Version | 1.0 |
---|
Creation date | 2011-09-21 00:24:48 UTC |
---|
Update date | 2018-05-28 18:35:17 UTC |
---|
Primary ID | FDB023109 |
---|
Secondary Accession Numbers | Not Available |
---|
Chemical Information |
---|
FooDB Name | Stanozolol |
---|
Description | Stanozolol was first synthesized by Clinton et al. in 1959, as a heterocyclic anabolic androgenic steroid. The structure of Stan differs from endogenous steroid hormones and most commercially available anabolic steroids. It most closely resembles methyl testosterone. Instead of the 3-ketogroup in methyltestosterone, there is a pyrazole ring fused to the androstane ring system. This slightly different structure has the disadvantage of making extraction and isolation of the molecule from matrices more difficult. Like most other anabolic steroids, Stan has poor gas chromatographic behavior and is difficult to detect in urine, because of renal clearance and low urinary excretion. This is due to the rapid metabolization, leading to low concentration levels of the parent compound found in urine. Therefore, most research studies had focused on the detection of urinary metabolites.
Androgens are drugs, derived from the natural male sex hormone testosterone, with high anabolic potential and minimized androgenic activity. Anabolic steroids stimulate protein synthesis, resulting in an acceleration of the food conversion rate and increasing muscle growth, body mass and enhanced performance. Androgens can be used as therapeutics, because they accelerate the recovery of protein deficiency and protein-wasting disorders (e.g. osteoporosis), but they are also widely abused in doping, as well in animals as in men. (PMID: 10404632, 10435307, 11175645, 11284331, 12064656, 12580506, 1448813, 14698206, 15013688, 15458725, 15631866, 15664350, 16040239, 16259046, 16288903, 1640693, 17066372, 17146762, 2306548, 2362445, 2625454, 2663904, 6539197, 9001957, 9300863, 9580049) [HMDB] |
---|
CAS Number | 10418-03-8 |
---|
Structure | |
---|
Synonyms | Synonym | Source |
---|
Androstanazole | ChEBI | Estanozolol | ChEBI | Stanozololum | ChEBI | Stromba | ChEBI | Strombaject | ChEBI | Winstrol | ChEBI | (5a,17b)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol | HMDB | 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-Trimethyl-cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol | HMDB | 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol | HMDB | 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol | HMDB | 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole | HMDB | 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole | HMDB | 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole | HMDB | 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8ci) | HMDB | Anabol | HMDB | Androstanazol | HMDB, MeSH | Androstanazolestanazol | HMDB | Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv. | HMDB | Estazol | HMDB | Stanazolol | HMDB, MeSH | Tevabolin | HMDB | Win 14833 | HMDB | Winstroid | HMDB | Winstrol depot | HMDB | Winstrol V | HMDB | Sanofi winthrop brand OF stanozolol | MeSH, HMDB | Zambon brand OF stanozolol | MeSH, HMDB | Methylstanazol | MeSH, HMDB | Sanofi-synthelabo brand OF stanozolol | MeSH, HMDB | (5a,17b)-17-methyl-2'H-Androst-2-eno[3,2-c]pyrazol-17-ol | hmdb | 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol | hmdb | 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI) | hmdb | Winstrol Depot | hmdb |
|
---|
Predicted Properties | |
---|
Chemical Formula | C21H32N2O |
---|
IUPAC name | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4,7-dien-17-ol |
---|
InChI Identifier | InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
---|
InChI Key | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
---|
Isomeric SMILES | [H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC3=NNC=C3C[C@]12C |
---|
Average Molecular Weight | 328.4916 |
---|
Monoisotopic Molecular Weight | 328.251463656 |
---|
Classification |
---|
Description | Belongs to the class of organic compounds known as estrane steroids. These are steroids with a structure based on the estrane skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrane steroids |
---|
Alternative Parents | |
---|
Substituents | - Estrane-skeleton
- Hydroxysteroid
- 17-hydroxysteroid
- Azole
- Cyclic alcohol
- Pyrazole
- Tertiary alcohol
- Heteroaromatic compound
- Organoheterocyclic compound
- Azacycle
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Disposition | Route of exposure: Source: Biological location: |
---|
Process | Naturally occurring process: |
---|
Role | Biological role: Industrial application: |
---|
Physico-Chemical Properties - Experimental |
---|
Physico-Chemical Properties - Experimental | Property | Value | Reference |
---|
Physical state | Solid | |
---|
Physical Description | Not Available | |
---|
Mass Composition | Not Available | |
---|
Melting Point | Not Available | |
---|
Boiling Point | Not Available | |
---|
Experimental Water Solubility | Not Available | |
---|
Experimental logP | Not Available | |
---|
Experimental pKa | Not Available | |
---|
Isoelectric point | Not Available | |
---|
Charge | Not Available | |
---|
Optical Rotation | Not Available | |
---|
Spectroscopic UV Data | Not Available | |
---|
Density | Not Available | |
---|
Refractive Index | Not Available | |
---|
|
---|
Spectra |
---|
Spectra | |
---|
EI-MS/GC-MS | Type | Description | Splash Key | View |
---|
Predicted GC-MS | Stanozolol, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0ika-1698000000-3f8c35eb18e311ca156b | Spectrum | Predicted GC-MS | Stanozolol, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0079-3249000000-250fe7ac2a107a020916 | Spectrum | Predicted GC-MS | Stanozolol, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
---|
MS/MS | Type | Description | Splash Key | View |
---|
MS/MS | LC-MS/MS Spectrum - 35V, Positive | splash10-004i-0009000000-092e853c1b3ea4cea476 | 2021-09-20 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03fr-0009000000-e44e17759e6628cd979d | 2016-08-02 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03dl-0092000000-fb2af0d825cd4939b25f | 2016-08-02 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0udj-9870000000-8e6ba7db421ffbe6d4d4 | 2016-08-02 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0009000000-f62def968e0fcaf5ad8b | 2016-08-03 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-002b-0096000000-6c72948a57cb2e8a7683 | 2016-08-03 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-03xr-6198000000-d225125a553d5bedac3e | 2016-08-03 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0009000000-507d1b76f5fbab2cd617 | 2021-09-24 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-0009000000-507d1b76f5fbab2cd617 | 2021-09-24 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-0039000000-a11542c5a5960f8c2e3a | 2021-09-24 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-004i-0019000000-e17ed5d1d401678c0a12 | 2021-09-24 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-2963000000-c456325d88b698b6ee3e | 2021-09-24 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0udr-1790000000-56ae15e8bf663dc1ee84 | 2021-09-24 | View Spectrum |
|
---|
NMR | Not Available |
---|
External Links |
---|
ChemSpider ID | 23582 |
---|
ChEMBL ID | CHEMBL2079587 |
---|
KEGG Compound ID | C07311 |
---|
Pubchem Compound ID | 25249 |
---|
Pubchem Substance ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Phenol-Explorer ID | Not Available |
---|
DrugBank ID | DB06718 |
---|
HMDB ID | HMDB03116 |
---|
CRC / DFC (Dictionary of Food Compounds) ID | Not Available |
---|
EAFUS ID | Not Available |
---|
Dr. Duke ID | Not Available |
---|
BIGG ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
HET ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
Flavornet ID | Not Available |
---|
GoodScent ID | Not Available |
---|
SuperScent ID | Not Available |
---|
Wikipedia ID | Stanozolol |
---|
Phenol-Explorer Metabolite ID | Not Available |
---|
Duplicate IDS | Not Available |
---|
Old DFC IDS | Not Available |
---|
Associated Foods |
---|
Food | Content Range | Average | Reference |
---|
Food | | | Reference |
---|
|
Biological Effects and Interactions |
---|
Health Effects / Bioactivities | Not Available |
---|
Enzymes | Not Available |
---|
Pathways | Not Available |
---|
Metabolism | Not Available |
---|
Biosynthesis | Not Available |
---|
Organoleptic Properties |
---|
Flavours | Not Available |
---|
Files |
---|
MSDS | show |
---|
References |
---|
Synthesis Reference | Not Available |
---|
General Reference | Not Available |
---|
Content Reference | |
---|